Gottlieb is a senior fellow at the American Enterprise Institute and served as commissioner of the Food and Drug Administration from 2017 to 2019. President Trump often touted during his first term ...

(CNN) — The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...

SHANGHAI, March 25 (Reuters) - Jiangsu Hengrui Pharmaceuticals, China's biggest drugmaker by market value, reported fourth-quarter profit below market expectations on Wednesday, as income from ...

Semaglutide, the key ingredient in Wegovy, which leads the global obesity treatment market, is losing patent protection in ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

Detailed price information for Sandoz Group Ag ADR (SDZNY) from The Globe and Mail including charting and trades.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Generic drug suppliers weigh predictable and unpredictable factors that could impact the category in 2025. “This is the latest example of our actions to expand our portfolio in growing therapeutic ...

With the patent on semaglutide having expired in India, the cost dynamics of the drug are beginning to shift. Earlier, ...

The Food and Drug Administration on Tuesday published a list of brand name drugs without generic competition and implemented a policy to accelerate generic drug approvals. The actions represent the ...